| Monoclonal Immunoglobulin Deposition Disease studied in …STUDIED_INderived148 of 148show fewer |
|---|
| → studied in | NCT06768489Phase 1 · recruiting A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma · condition mapped ALIAS · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07172243recruiting BE.Amycon Biobank & Data Registry UZ Leuven · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05283993recruiting A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07215494NA · recruiting A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis · condition mapped ALIAS · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07103863enrolling by invitation Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07615270early Phase 1 · not yet recruiting A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05145816Phase 1/Phase 2 · recruiting Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06569147Phase 1/Phase 2 · recruiting Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07751471Phase 2 · not yet recruiting BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004) · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01169337Phase 3 · active not recruiting Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05184088Phase 3 · completed Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07638683Phase 2 · recruiting A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL). · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04617925Phase 2 · completed A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04847453Phase 1 · active not recruiting Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis · condition mapped CURATED_BROADER · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07335887Phase 2 · recruiting Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06649695Phase 2 · active not recruiting A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06855121recruiting The Norwegian Immunotherapy in Multiple Myeloma Study · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224672Phase 2 · recruiting A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04754945Phase 1 · active not recruiting Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06097832Phase 1/Phase 2 · active not recruiting Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis · condition mapped ALIAS · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05451771Phase 1/Phase 2 · active not recruiting Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03283917Phase 1 · completed Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis · condition mapped CURATED_BROADER · 148 trials mapped (54 active) | — | — | Primary Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07689331recruiting Hungarian National Systemic Amyloidosis Registry · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06192979NA · recruiting Optimize First-line Treatment for AL Amyloidosis With t (11; 14) · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04504825Phase 3 · active not recruiting A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES) · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07081646Phase 1/Phase 2 · recruiting A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis. · condition mapped CURATED_BROADER · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06971848NA · recruiting Evaluation of Skin Tests in Biotherapy Allergies · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04512235Phase 3 · active not recruiting A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES) · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07626476early Phase 1 · recruiting Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07624760NA · not yet recruiting Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03820817Phase 1 · completed Rifaximin in Patients With Monoclonal Gammopathy · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07585331completed Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06022939Phase 3 · recruiting Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07448935recruiting One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06769555NA · withdrawn BCMA/CD3 BiTE for RRAL or NDAL Amyloidosis With Insufficient Depth of Hematologic Response After Induction Therapy · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04392960NA · completed Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04839003recruiting A Registry of AL Amyloidosis (ReAL) · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06205953recruiting A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA) · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06383143recruiting Promoting Diagnosis and Management of AL in Italy (ProDigALIty) · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05898646Phase 2 · recruiting Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01408225recruiting Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03431896completed Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01758042NA · completed Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07448779recruiting Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04270175Phase 2 · active not recruiting Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03123029available Expanded Access to Venetoclax · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06573723recruiting Institutional Registry of Rare Diseases · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04991103Phase 2 · recruiting Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE) · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05556928recruiting Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03618537Phase 2 · active not recruiting Ixazomib Maintenance Study in Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03717844recruiting Registry for Adults With Plasma Cell Disorders (PCD's) · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02641145NA · recruiting Molecular Imaging of Primary Amyloid Cardiomyopathy · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03315026Phase 2 · active not recruiting Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Multiple Myeloma and AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02909036Phase 1 · active not recruiting Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant. · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03499808Phase 2 · completed S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07085559early Phase 1 · recruiting Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01864018Phase 1/Phase 2 · completed Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07079423Phase 2 · recruiting Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07055724Phase 2 · not yet recruiting Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06935162Phase 2 · recruiting Teclistamab in Previously Treated AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06699394NA · recruiting Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02924272Phase 2 · completed Ixazomib Rollover Study · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05486481Phase 1/Phase 2 · withdrawn Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE) · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04304144Phase 2 · completed A Study to Evaluate the Safety and Tolerability of CAEL-101 in Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04895917Phase 2 · terminated Daratumumab and Pomalidomide in Previously Treated Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02245867Phase 1 · completed Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06539169unknown FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05260203NA · completed MargheRITA (Remote Intelligence for Therapeutic Adherence) · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05199337Phase 1/Phase 2 · completed Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04659798completed A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice · condition mapped ALIAS · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05635266unknown Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06376214NA · recruiting Daratumumab for Patients With Light Chain Amyloidosis · condition mapped ALIAS · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05066607Phase 2 · unknown Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04210791enrolling by invitation Autologous Stem Cell Transplantation for Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06186167unknown Amyloidosis Incidence in High-Risk Cardiac Device Patients · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00520767Phase 2 · completed Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05028374Phase 2 · completed COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04942067Phase 1/Phase 2 · unknown APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06065852recruiting National Registry of Rare Kidney Diseases · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Monoclonal Immunoglobulin Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05174338unknown Cardiac Amyloidosis Registry Study · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03959358Phase 2 · completed A Study to Desensitize Allergic Reactions to Treatments for Blood Disorders · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00224393Phase 2 · completed Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01728259Phase 1 · terminated First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05776940Phase 3 · unknown Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis · condition mapped ALIAS · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03252600Phase 2 · unknown Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis · condition mapped CURATED_BROADER · 148 trials mapped (54 active) | — | — | Primary Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02158052NA · completed Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04984330early Phase 1 · withdrawn Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03236792Phase 1/Phase 2 · completed Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04937777completed A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01849783Phase 2 · completed Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05277493unknown A Registry of Chinese AL Amyloidosis Patients Treated With Subcutaneous or Intravenous Daratumumab · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04115956Phase 1 · terminated A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01078454Phase 3 · completed Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02589860withdrawn Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03886155completed Cardiac Amyloidosis Screening at Trigger Finger Release · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03923920completed Screening for Systemic Amyloidosis Via the Ligamentum Flavum · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02716103completed Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02207556Phase 2 · completed Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02841033Phase 1/Phase 2 · completed Daratumumab for the Treatment of Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00981708Phase 1/Phase 2 · completed Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL) · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00536601NA · completed High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02545907Phase 1/Phase 2 · completed A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04612582Phase 4 · unknown Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis · condition mapped ALIAS · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01083316Phase 2 · completed Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01570387Phase 1/Phase 2 · completed A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02555969completed Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03000660Phase 1 · terminated Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01383759NA · completed Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Monoclonal Immunoglobulin Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01222260Phase 2 · completed Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006251Phase 1/Phase 2 · completed Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014235NA · completed Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00651937Phase 2 · completed Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02603172Phase 1 · terminated A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02613182Phase 2 · terminated Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02574676completed Quality of Life (QOL) Registry for Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02632786Phase 2 · completed The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03154047Phase 2 · terminated Study in Subjects With Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02489500Phase 3 · terminated Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01707264Phase 1/Phase 2 · completed Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01777243Phase 1 · completed A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01053494NA · completed Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00952237Phase 1 · completed Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF · condition mapped PROBABILISTIC · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02791373Phase 2 · completed Vinorelbine and Gemcitabine in Myeloma · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01677286Phase 2 · completed Safety and Effect of Doxycycline in Patients With Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01406314Phase 1 · completed SAP Depleter Dose Assessment Study in Patients · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01194791Phase 2 · completed Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890552NA · completed A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01277016Phase 3 · completed A Trial for Systemic Light-chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02953808Phase 1 · completed Phase 1 Study of GSK2315698 in Healthy Japanese Subjects · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01135849completed B-Receptor Signaling in Cardiomyopathy · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02257905completed Allo SCT in Amyloidosis Non-interventional Study · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01533194Phase 1 · completed Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00919139completed S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS. · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01072773Phase 2 · completed Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Light Chain Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00890747Phase 1 · completed Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Light Chain Deposition Disease | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01998503Phase 3 · completed Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00883623Phase 2 · completed A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00807872Phase 1 · completed Radioimmunoimaging of AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01815086Phase 1 · completed Radioimmunoimaging of Light Chain (AL) Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00025415Phase 1 · completed Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030381Phase 1 · terminated Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01409148Phase 1 · completed Radioimmunoimaging of AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00621400Phase 1/Phase 2 · completed Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00017680Phase 2 · completed Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00344526Phase 3 · completed Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active) | — | — | Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |